Skip to main content

News & Media

Stay up to date on the latest news, announcements, and insights from Padagis. Explore how
we’re advancing access to affordable healthcare and making an impact across the industry.

Media Inquires: [email protected]

Filter

Padagis Invests More Than $36 Million to Expand Manufacturing in the U.S.
Newspaper
Padagis Invests More Than $36 Million to Expand Manufacturing in the U.S.

Padagis Invests More Than $36 Million to Expand Manufacturing in the U.S.

October 28, 2025
ALLEGAN, Mich., Oct. 28, 2025 /PRNewswire/ -- Padagis®, a leading generic pharmaceuticals company, has announced an investment of over $36 million to expand its manufacturing operations in Minneapolis, Minnesota, which includes the expansion…
Read More
Padagis and The Naloxone Project Partner to Expand Nationwide Access to Lifesaving Naloxone
Padagis and The Naloxone Project Partner to Expand Nationwide Access to Lifesaving Naloxone

Padagis and The Naloxone Project Partner to Expand Nationwide Access to Lifesaving Naloxone

September 23, 2025
ALLEGAN, Mich., Sept. 23, 2025 /PRNewswire/ -- Padagis®, a leader in generic pharmaceuticals, today announced a partnership with The Naloxone Project (TNP) to expand access across the U.S. to its life-saving generic naloxone nasal…
Read More
State of Michigan Expands Naloxone Access with Generic Naloxone Nasal Spray from Hometown Manufacturer, Padagis
Newspaper
State of Michigan Expands Naloxone Access with Generic Naloxone Nasal Spray from Hometown Manufacturer, Padagis

State of Michigan Expands Naloxone Access with Generic Naloxone Nasal Spray from Hometown Manufacturer, Padagis

July 8, 2025
ALLEGAN, Mich., July 8, 2025 /PRNewswire/ -- Padagis®, a Michigan-based leader in generic pharmaceuticals, announced today that the State of Michigan has added its over-the-counter (OTC) Naloxone HCl Nasal Spray 4 mg to the state's distribution network. This…
Read More
Padagis Extends the Shelf-Life of Naloxone HCl Nasal Spray 4 mg to 36 Months
Padagis Extends the Shelf-Life of Naloxone HCl Nasal Spray 4 mg to 36 Months

Padagis Extends the Shelf-Life of Naloxone HCl Nasal Spray 4 mg to 36 Months

April 2, 2025
ALLEGAN, Mich., April 2, 2025 /PRNewswire/ -- Padagis®, a leading generic manufacturer, announced today its over-the-counter (OTC) Naloxone HCl Nasal Spray 4 mg has now obtained an extended shelf-life of 36 months. Padagis' Naloxone…
Read More
Padagis Naloxone Now the Lowest Priced Opioid Overdose Treatment Available on Amazon
Newspaper
Padagis Naloxone Now the Lowest Priced Opioid Overdose Treatment Available on Amazon

Padagis Naloxone Now the Lowest Priced Opioid Overdose Treatment Available on Amazon

February 3, 2025
ALLEGAN, Mich., Feb. 3, 2025 /PRNewswire/ -- Padagis®, a leading generic manufacturer, announced today it is lowering the price of its over-the-counter (OTC) 4 mg Naloxone HCl Nasal Spray to $29.99 on Amazon. This makes…
Read More
Padagis Donates 15K Units of Naloxone to End Overdose to Distribute on College Campus’ Nationwide
Padagis Donates 15K Units of Naloxone to End Overdose to Distribute on College Campus’ Nationwide

Padagis Donates 15K Units of Naloxone to End Overdose to Distribute on College Campus’ Nationwide

November 19, 2024
ALLEGAN, Mich., Nov. 19, 2024 /PRNewswire/ -- According to recent data from the Centers for Disease Control and Prevention, overdose death rates have spiked dramatically for young adults, rising 34 percent in four…
Read More